PDCD1LG2 and neoplasm: This function is achieved by binding to its ligands, PD-L1, which is expressed in various cell types, including tumor cells, and PD-L2 (programmed death-ligand 2), expressed on immune cells such as dendritic cells and macrophages [13,58].